BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Roger Song does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 KNSAKiniksa Pharmaceuticals Ltd | Buy | $45.00 | Apr 2025 | +93.0% | Hit |
 AKBAAkebia Ther | Buy | $6.00 | Apr 2025 | −31.1% | Miss |
 SANASana Biotechnology Inc | Buy | $7.00 | Mar 2025 | +13.4% | Miss |
 ACRSAclaris Therapeutics Inc | Buy | $7.00 | Nov 2024 | −46.4% | Miss |
 BIOABioAge Labs, Inc | Buy | $42.00 | Oct 2024 | −75.4% | Miss |
 NVAXNovavax Inc | Buy | $25.00 | Oct 2024 | −13.1% | Miss |
 ZBIOZenas BioPharma, Inc. Common Stock | Buy | $35.00 | Oct 2024 | +55.5% | Miss |
| NVAXNovavax Inc | Buy | $31.00 | Oct 2024 | −30.0% | Miss |
| KNSAKiniksa Pharmaceuticals Ltd | Buy | $40.00 | Sep 2024 | +56.7% | Miss |
 ATYRaTyr Pharma, Inc. | Buy | $9.00 | Sep 2024 | +207.3% | Miss |
 PCVXVaxcyte Inc | Buy | $129.00 | Sep 2024 | −59.5% | Miss |
 CRVSCorvus Pharmaceuticals Inc | Buy | $8.00 | Dec 2021 | −79.4% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.